Status: Recruiting
Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan
randomised control clinical trial to evaluate miltefosine, thermotherapy and the combination miltefosine-thermotherapy are effective, safe and tolerable alternative treatment options to treat cutaneous leishmaniasis caused by L. tropica, in Pakistan compared to the standard of care.
Participants needed: 832
Trial details
Phase: Phase 3Age: 10+Biological sex: AllType: InterventionalSponsor: Medecins Sans Frontieres, NetherlandsUpdated: May 9, 2025Locations: 2
Eligibility criteria
lesion size ≥0.5 cm and ≤4 cm [+4]
Pregnant women and breast feeding women [+9]